FDA Inspection
Avioq, Inc.Avioq, Inc. – FDA Inspection, Dec 5, 2023
Record Details
This FDA Inspection record concerns Avioq, Inc., with an inspection on December 5, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f2c7c80a-a712-4173-8498-cea59c9bef05
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224168
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 820.184DHR - not or inadequately maintained
- 21 CFR 820.60Identification procedures, Lack of or inadequate procedures
- 21 CFR 820.150Lack of or inadequate procedures for storage.
- 21 CFR 820.150Lack of or inadequate procedures for storage.
- 21 CFR 820.184DHR - not or inadequately maintained
- 21 CFR 820.60Identification procedures, Lack of or inadequate procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Avioq, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 14, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| February 27, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 17, 2017 | Not classified | Atlanta District Office | |
| January 13, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 27, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Avioq, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.